Fibromyalgia

Davydov, O.S.; Glebov, M.V.

doi:10.17116/pain20201803166

Rus. Jour. of Pain

2020

DOI: 10.17116/pain20201803166

|View full text |Cite

Fibromyalgia

O.S. Davydov¹,

M.V. Glebov²

Abstract: Фибромиалгия-заболевание, характеризующееся сочетанием хронической распространенной мышечной боли и широкого спектра ассоциированных психосоматических проявлений, таких как утомляемость, нарушения сна, общая скованность, депрессия, тревожность, когнитивные расстройства. Распространенность фибромиалгии в общей популяции варьирует от 2 до 4%. Несмотря на достижения последних десятилетий в изучении такой проблемы, фибромиалгия остается редко диагностируемым и труднокурабельным заболеванием. Цель работы-обобщение … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 9 publications

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia

Nasonova

Парфенова

2022

RJTAO

View full text Add to dashboard Cite

Fibromyalgia (FM) often occurs under the mask of non-specific low back pain (NLBP).Objective: to compare the combined disorders and treatment efficacy in FM and chronic NLBP (chNLBP).Patients and methods. We examined 33 patients with chNLBP (27 women and 6 men, mean age 51.5±16.7 years) and 53 patients with FM (47 women and 6 men, mean age 46.8±14.6 years). Pain intensity was assessed using a numerical rating scale (NRS), using the Hospital Anxiety and Depression Scale (HADS), the Screening for Somatoform Symptoms-2 (SOMS-2), the Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), updated Fibromyalgia Impact Questionnaire (FIQR; disability in patients with FM), Oswestry Index (IO; disability in patients with chNLBP). Comprehensive treatment of patients included educational conversations, cognitive behavioral therapy, kinesitherapy, among drugs antidepressants, and in patients with FM anticonvulsants.Results and discussion. Previously, the diagnosis of FM was established only in 15% of patients, the diagnosis of chNLBP – in 82% of patients. The intensity of pain in FM was 7.1±1.9 points according to the NRS and was higher than in chNLBP (5.6±2.4 points; p=0.002). In the group of patients with FM compared to patients with chNLBP, significantly higher values of anxiety according to HADS (10.9±4.5 and 6.9±4.0 points; p<0.001), sleepiness according to ESS (8.2±4.6 and 6.2±4.6 points; p=0.014), somatization according to SOMS-2 (28.0 and 20.0 points; p<0.001) were detected. Possible anatomical causes of pain have been identified in all patients with chNLBP and only in 13% of patients with FM. 6 months after thestart of treatment in the FM group, pain intensity significantly (p<0.001) decreased to 3.7±2.6 points according to the NRS, anxiety to 6.7±3.5 points according to HADS, depression to 4.7±2 .6 points according to HADS, disability from 54.9±18.4 to 34.0±20.2 points according to FIQR; in chNLBP group pain intensity significantly (p<0.05) decreased to 2.6±2.1 points according to the NRS, anxiety decreased to 4.2±2.5 points according to HADS, depression to 6.5±3.3 points according to HADS, disability from 37.8±17.4 to 14.5±14.2 points according to IO.Conclusion. FM is less frequently diagnosed in comparison with chNLBP, accompanied by a higher pain intensity, anxiety, sleepiness and somatization. Complex therapy leads to a stable positive effect both in chNLBP and in FM.

show abstract

Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia

Nasonova

Парфенова

2022

RJTAO

View full text Add to dashboard Cite

show abstract

Russian language version of the Central Sensitization Inventory: A study of validity and reliability in nonspecific neck pain, accompanied by headaches

Bakhtadze¹,

Кукушкин²,

Филатова³

et al. 2022

Rus. Jour. of Pain

View full text Add to dashboard Cite

Fibromyalgia rapid screening tool: linguistic adaptation of the Russian version

Nasonova¹,

Bakhtadze²,

Mukhametzyanova³

et al. 2022

Rus. Jour. of Pain

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Fibromyalgia

Cited by 9 publications

References 56 publications

Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia

Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia

Russian language version of the Central Sensitization Inventory: A study of validity and reliability in nonspecific neck pain, accompanied by headaches

Fibromyalgia rapid screening tool: linguistic adaptation of the Russian version

Contact Info

Product

Resources

About